BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15205195)

  • 1. 5-Fluorouracil incorporation into RNA and DNA in relation to thymidylate synthase inhibition of human colorectal cancers.
    Noordhuis P; Holwerda U; Van der Wilt CL; Van Groeningen CJ; Smid K; Meijer S; Pinedo HM; Peters GJ
    Ann Oncol; 2004 Jul; 15(7):1025-32. PubMed ID: 15205195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Critical Function of microRNAs in Developing Resistance against 5- Fluorouracil in Cancer Cells.
    Sheikhnia F; Maghsoudi H; Majidinia M
    Mini Rev Med Chem; 2024; 24(6):601-617. PubMed ID: 37642002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effect of methionine-depleting total parenteral nutrition with 5-fluorouracil on human gastric cancer: a randomized, prospective clinical trial.
    Goseki N; Yamazaki S; Shimojyu K; Kando F; Maruyama M; Endo M; Koike M; Takahashi H
    Jpn J Cancer Res; 1995 May; 86(5):484-9. PubMed ID: 7790321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standing the test of time: targeting thymidylate biosynthesis in cancer therapy.
    Wilson PM; Danenberg PV; Johnston PG; Lenz HJ; Ladner RD
    Nat Rev Clin Oncol; 2014 May; 11(5):282-98. PubMed ID: 24732946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention by chitosan of myelotoxicity, gastrointestinal toxicity and immunocompetent organic toxicity induced by 5-fluorouracil without loss of antitumor activity in mice.
    Kimura Y; Okuda H
    Jpn J Cancer Res; 1999 Jul; 90(7):765-74. PubMed ID: 10470290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A forward genetic approach for analyzing the mechanism of resistance to the anti-cancer drug, 5-fluorouracil, using Caenorhabditis elegans.
    Kim S; Shim J
    Mol Cells; 2008 Feb; 25(1):119-23. PubMed ID: 18319623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Participation of DNA repair in the response to 5-fluorouracil.
    Wyatt MD; Wilson DM
    Cell Mol Life Sci; 2009 Mar; 66(5):788-99. PubMed ID: 18979208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An RNA Damage Response Network Mediates the Lethality of 5-FU in Clinically Relevant Tumor Types.
    Chen JK; Merrick KA; Kong YW; Izrael-Tomasevic A; Eng G; Handly ED; Patterson JC; Cannell IG; Suarez-Lopez L; Hosios AM; Dinh A; Kirkpatrick DS; Yu K; Rose CM; Hernandez JM; Hwangbo H; Palmer AC; Vander Heiden MG; Yilmaz ÖH; Yaffe MB
    bioRxiv; 2023 Apr; ():. PubMed ID: 37162991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Fluorouracil Treatment Represses Pseudouridine-Containing Small RNA Export into Extracellular Vesicles.
    Qu S; Nelson H; Liu X; Semler E; Michell DL; Massick C; Franklin JL; Karijolich J; Weaver AM; Coffey RJ; Liu Q; Vickers KC; Patton JG
    bioRxiv; 2024 Jan; ():. PubMed ID: 38293013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The incorporation of 5-fluorouracil into RNA affects the ribonucleolytic activity of the exosome subunit Rrp6.
    Silverstein RA; González de Valdivia E; Visa N
    Mol Cancer Res; 2011 Mar; 9(3):332-40. PubMed ID: 21289297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Fluorouracil incorporated into DNA is excised by the Smug1 DNA glycosylase to reduce drug cytotoxicity.
    An Q; Robins P; Lindahl T; Barnes DE
    Cancer Res; 2007 Feb; 67(3):940-5. PubMed ID: 17283124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of action of FdUMP[10]: metabolite activation and thymidylate synthase inhibition.
    Bijnsdorp IV; Comijn EM; Padron JM; Gmeiner WH; Peters GJ
    Oncol Rep; 2007 Jul; 18(1):287-91. PubMed ID: 17549381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processes.
    Blondy S; David V; Verdier M; Mathonnet M; Perraud A; Christou N
    Cancer Sci; 2020 Sep; 111(9):3142-3154. PubMed ID: 32536012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future.
    Vodenkova S; Buchler T; Cervena K; Veskrnova V; Vodicka P; Vymetalkova V
    Pharmacol Ther; 2020 Feb; 206():107447. PubMed ID: 31756363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel insights into the role of translesion synthesis polymerase in DNA incorporation and bypass of 5-fluorouracil in colorectal cancer.
    Averill JR; Lin JC; Jung J; Jung H
    Nucleic Acids Res; 2024 May; 52(8):4295-4312. PubMed ID: 38416579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-548c-3p through suppressing
    Khalili E; Afgar A; Rajabpour A; Aghaee-Bakhtiari SH; Jamialahmadi K; Teimoori-Toolabi L
    Heliyon; 2023 Nov; 9(11):e21775. PubMed ID: 38045156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unnatural Amino Acid Engineering for Intracellular Delivery of Protein Therapeutics.
    Chen W; Sullivan MO
    Methods Mol Biol; 2024; 2720():151-164. PubMed ID: 37775664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing the Effective Chemotherapy: The Combined Inhibition of Rhinacanthin-C, 5-Fluorouracil, and Etoposide on Oral Cancer Cells.
    Klaophimai S; Pouyfung P; Chairatvit K
    Asian Pac J Cancer Prev; 2023 Jul; 24(7):2405-2412. PubMed ID: 37505773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of 5-FU resistance mechanisms in colorectal cancer: clinical significance of attenuated on-target effects.
    Gmeiner WH; Okechukwu CC
    Cancer Drug Resist; 2023; 6(2):257-272. PubMed ID: 37457133
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.